The FDA conducted an unannounced on-site inspection of the headquarters of electronic-cigarette manufacturer Juul Labs at the end of September, focusing its inquiry on the company’s sales and marketing practices, the agency said.

As part of its ongoing efforts to prevent youth use of tobacco products, particularly e-cigarettes, it conducted the inspection Sept. 28 and collected “over 1,000 pages of documents,” it said.

San Francisco-based Juul did not respond to CSP’s request for comment by press time, but previously it has said it intends to cooperate with FDA inquiries.

Photograph by CSP Staff